{
    "nctId": "NCT03036475",
    "briefTitle": "Sienna and Sentimag in Sentinel Lymph Node Biopsy",
    "officialTitle": "Sentinel Lymph Node Biopsy Using a Magnetic Tracer Versus Standard Radio-isotope Technique in Early Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 52,
    "primaryOutcomeMeasure": "Proportion of successful procedures for sentinel lymph node identification (identification rate per patient) by the magnetic method compared with the standard method",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women diagnosed with early-stage breast cancer (including ductal carcinoma in-situ) who are clinically or radiologically node-negative and consenting for sentinel lymph node biopsy\n* Patients undergoing SNOLL (Sentinel node and occult lesion localization) with the use of radio-isotope in our Breast Centre\n\nExclusion Criteria:\n\n* Patients with clinically T3 or T4 breast cancer and any contraindication to sentinel lymph node biopsy\n* Patients with pacemaker or other implantable device in the chest wall",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}